Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Demonstrates Applicability of Drug Delivery Platform Through Relationships with Fortune 500 Leaders
Lexaria’s DehydraTECH(TM) drug delivery platform a feasible and healthier alternative to other delivery methods The fast-acting, high absorption technology improves dipping experience and consumer satisfaction Company expects to more than double its 2019 revenue this year, will pursue a new capital markets strategy to qualify for listing on a nationally recognized U.S. exchange Lexaria Bioscience … Continue reading “Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Demonstrates Applicability of Drug Delivery Platform Through Relationships with Fortune 500 Leaders”